|
The Draft Resolution No. 1050, 31 May 2021 – previously notified through G/TBT/N/BRA/1193 – which contains provisions on risk assessment and control of potentially carcinogenic nitrosamines in drugs for human use, was adopted as Resolution – RDC number 677, 28 April 2022.
|